Nimotuzumab

Nimotuzumab is a humanized monoclonal antibody, which is used for the treatment and prevention of glioma, in both adults and children alike. Nimotuzumab is a highly-selective epidermal growth factor (EGF) receptor antagonist which works to increase angiogenesis, cellular proliferation, apoptosis and cell motility in malignant cells.

Nimotuzumab is administered in combination with radiotherapy or chemotherapy, with the dose depending on the patient’s condition and the doctor’s diagnosis. The medicine is distributed evenly in the heart, liver, bladder, kidneys and spleen.

Administration of Nimotuzumab should be exercised with caution in patients who have a history of murine monoclonal antibodies, patients with theracim hypersensitivity, as well as patients who have a history of diabetes and a history of cardiac diseases/problems.

Nimotuzumab should not be administered to women who are pregnant and/or breastfeeding. Common side effects of Nimotuzumab include fever, chills, nausea, vomiting, asthenia, hypotension or hypertension, flushing, dryness of mouth, rash, headache, fluctuation in blood pressure, dizziness and lightheadedness.

Information given here is based on the salt content of the medicine. Uses and effects of the medicine may vary from person to person. It is advisable to consult a Oncologist before using this medicine.

• Head And Neck Cancer

• Cancer Of Colon And Rectum

Information given here is based on the salt content of the medicine. Uses and effects of the medicine may vary from person to person. It is advisable to consult a Oncologist before using this medicine.

• Weakness

• Vomiting

• Dizziness

• Blood In Urine

• Diarrhoea

Information given here is based on the salt content of the medicine. Uses and effects of the medicine may vary from person to person. It is advisable to consult a Oncologist before using this medicine.

• Is It safe with alcohol?

  Interaction with alcohol is unknown. Please consult your doctor.

• Are there any pregnancy warnings?

  Biomab egfr 50mg injection may be unsafe to use during pregnancy.
  Animal studies have shown adverse effects on the foetus, however, there are limited human studies. The benefits from use in pregnant women may be acceptable despite the risk. Please consult your doctor.

• Are there any breast-feeding warnings?

  Unknown. Human and animal studies are not available. Please consult your doctor.

• Is it safe to drive while on this medicine?

  There is no data available. Please consult doctor before consuming the drug.

• Does this affect kidney function?

  There is no data available. Please consult doctor before consuming the drug.

• Does this affect liver function?

  There is no data available. Please consult doctor before consuming the drug.

Information given here is based on the salt content of the medicine. Uses and effects of the medicine may vary from person to person. It is advisable to consult a Oncologist before using this medicine.

• Are there any missed dose instructions?

  If you miss a dose of Nimotuzumab, please consult your doctor.

Information given here is based on the salt content of the medicine. Uses and effects of the medicine may vary from person to person. It is advisable to consult a Oncologist before using this medicine.

Below is the list of medicines, which contains Nimotuzumab as ingredient

• Biomab Egfr 50Mg Injection

  Biocon

Information given here is based on the salt content of the medicine. Uses and effects of the medicine may vary from person to person. It is advisable to consult a Oncologist before using this medicine.

This medicine works by targeting the epidermal growth factor receptor with superior potency, thereby inhibiting receptor activation and ligand binding. This drug is used in the treatment of squamous cell carcinomas of the head and neck.

Information given here is based on the salt content of the medicine. Uses and effects of the medicine may vary from person to person. It is advisable to consult a Oncologist before using this medicine.